JB and ZJMY Holding Co (JBZY)

[mr green239]

Interesting read about a huge Chinese scam. US investors lost a lot of money.
Companies include Shanghai Yutong Pharmaceuticals, Inc.
-http://finance.sina.com.cn/g/20071206/01204255837.shtml
The Chinese Sina article very interesting in my opinion.

https://www.riskstorm.com/company/310000000003768

RICHARD ORAVEC did a lot of work for Shanghai Yutong Pharmaceuticals, Inc. back around 2005.
- https://backend.otcmarkets.com/otcapi/company/financial-report/3753/content
- https://www.sec.gov/Archives/edgar/data/1353327/000110801706000164/ex103.htm
^ note: CHVI office located at 126 East 83rd St. Suite 3B New York City.
^^ ROGER L. FIDLER has/had his office located at 126 East 83rd St. Suite 3B New York City on several occasions.
^^ -http://securities.stanford.edu/filings-documents/1043/SPNG09_01/2010921_f01k_09CV08616.html
^^ This document is unrelated to the above but shows Fidlers address being used where he is representing JBZY's accountant JOHN DELLADONA (Among others..)

Anyways these three men (ORAVEC, DELLADONA, FIDLER) very experienced in these Chinese companies! Future should be interesting for JBZY!

Child Vision, Inc. enters into purchase agreement with Shanghai based Investment firm. New York (CHVI:OTC) On June 3rd, 2005 an investment group lead by Lu Jiang'an entered into an agreement to purchase the control stock of Child Vision, Inc., a Delaware Corporation. Pursuant to the purchase document, Lu Jiang'an has purchased 3,600,000 shares of common stock that represents approximately 99% of all outstanding shares of Child Vision, Inc. In connection with this Agreement,
Lu Jiang'an was appointed as designee to the Board of Directors and appointed Chairman of the Board of Directors. On June 14th, 2005, the transaction was completed and Mr. Lu Jiang'an was appointed as President and Chairman of the Board of Directors with Yang Weiquan appointed as Secretary and Treasurer and Mr. Wei Dong named as Chief Operating Officer to the Board of Directors. The company also authorized an increase in the authorized share capital from twenty million shares to fifty million as well as enacting a five for one forward split of all common outstanding shares. The Board of Directors has also agreed to change the name from Child Vision, Inc. to Shanghai Yutong Pharmaceuticals, Inc within due course. Legal Disclaimer The statements contained in this press release contain certain forward looking statements, including statements regarding the company's expectations, intentions, strategies and beliefs regarding the future. All statements contained herein are based upon information available to
the company's management as of the date hereof, and actual results may vary based upon future events, both within and without the control of the company's management. For Further Information: Rick Oravec [e-mail] 212-422-3601